CCCCCCNC(=O)O[C@H]1Cn2c(=O)ccc(=O)n2[C@@H]2CN(S(=O)(=O)c3ccc(C)cc3)C[C@]12O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?